Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoadjuvant Therapy × Plasma cell × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3 Gastrointestinal 2 Thoracic 1 Sarcoma 1 Plasma cell 1 Head & Neck 1 Gynecologic 1 Dermatologic 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 64 Lenalidomide 38 daratumumab 36 Bortezomib 31 Cyclophosphamide 26 pomalidomide 23 Calcium Dobesilate 22 carfilzomib 20 Biopsy 19 Specimen Handling 18 Magnetic Resonance Spectroscopy 16 fludarabine 15 talquetamab 14 iberdomide 11 dexamethasone acetate 11 dexamethasone 21-phosphate 11 auricularum 11 selinexor 8 isatuximab 8 trametinib 6 fludarabine phosphate 6 belantamab mafodotin 5 venetoclax 4 tocilizumab 4 dabrafenib 4 X-Rays 4 Whole-Body Irradiation 4 nirogacestat 3 elotuzumab 3 Sunitinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07149857 2026-03-13

CARTITUDE-10

Janssen Research & Development, LLC

Phase 2 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡